Financials
Value Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.76 M2.76 M3.03 M — Research & development 9 00010 K— — Operating income 118 K-3.63 M-2.2 M — Non-Operating Income, Total -285 K-51 K38 K — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses -285 K-51 K38 K — Unusual income/expense ——— — Pretax income -167 K-3.69 M-2.16 M — Equity in earnings ——— — Taxes 1 00000 — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -168 K-3.51 M-2.16 M — Discontinued operations ——— — Net income -168 K-3.51 M-2.16 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -168 K-3.68 M-2.16 M — Basic earnings per share (Basic EPS) -0.03-0.69-0.33 — Diluted earnings per share (Diluted EPS) -0.03-0.69-0.33 — Average basic shares outstanding 5 M5.26 M6.62 M — Diluted shares outstanding 5 M5.26 M6.62 M — EBITDA ——— — EBIT 118 K-3.63 M-2.2 M — Cost of revenue 3.36 M5.55 M3.6 M — Other cost of goods sold 0300 K— — Depreciation & amortization (cash flow) ——— —